- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04054622
Patient-ventilator Asychrony During Non-invasive Ventilation When COPD Patients Doing Exercise
February 20, 2021 updated by: Zhenfeng He, Guangzhou Medical University
Pulmonary rehabilitation programmes including aerobic exercise training have strong evidence of effectiveness in improving exercise capacity, dyspnoea and HRQL in patients with COPD.
Therefore, current guidelines recommend pulmonary rehabilitation, including exercise training, in these patients.
Non-invasive ventilation(NIV) is increasingly used during exercise training programmes in order to train patients at intensity levels higher than allowed by their clinical and pathophysiological conditions.
Patient-ventilator asynchrony (PVA) describes the poor interaction between the patient and the ventilator and is the consequence of the respiratory muscle activity of the patient being opposed to the action of the ventilator.PVA have unfavourable clinical impace on gas exchange, dyspnoea perception, patient comfort and tolerance and reduced adherence to NIV.
This study is going to detect whether the PVA will increase when COPD patients exercise with NIV supporingt
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China
- Recruiting
- The First Affiliated Hospital of Guangzhou Medical University.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with COPD, according to the criteria set by the Global Initiative for Obstructive Lung Disease scientific committee, were asked to participate in the present study.
Patients had to meet the following inclusion criteria: 1) Age 40-80, males and females; 2) Stage III and IV COPD; 3) Similar with non-invasive ventilation; 4) Willing to participate in the study; 5) Able to provide informed consent.
Description
Inclusion Criteria:
- Age 40-80, males and females;
- Stage III and IV COPD;
- Similar with non-invasive ventilation;
- Willing to participate in the study;
- Able to provide informed consent.
Exclusion Criteria:
- Presented with an acute exacerbation during previous 3 months;
- Bronchiectasis; post-tuberculosis sequelae; rib cage deformities; neuromuscular disorders; and bronchial carcinoma.
- Intolerant with NIV
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Asynchrony index
Time Frame: 5 hours
|
Asynchrony index is defined as the number of asynchrony events divided by the total respiratory rate computed as the sum of the number of ventilator cycles (triggered or not) and of wasted efforts: asynchrony Index (expressed in percentage) = number of asynchrony events/total respiratory rate (ventilator cycles +wasted efforts) × 100
|
5 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Severe Respiratory Insufficiency (SRI) Questionnaire
Time Frame: 5 hours
|
The SRI Questionnaire has good psychometric properties shown to be valid for chronic hypercapnic COPD patients receiving NIV.
It includes 49 items on seven subscales.
|
5 hours
|
COPD assessment test
Time Frame: 5 hours
|
The COPD Assessment Test is a questionnaire for people with COPD.
It is designed to measure the impact of COPD on a person's life, and how this changes over time.
|
5 hours
|
Partial pressure of arterial blood carbon dioxide (PaCO2)
Time Frame: 5 hours
|
Daytime arterial blood gas samples were taken with patients resting in a sitting position and breathing room air without having used NIV for at least 1 hour.
|
5 hours
|
6-minute walk test
Time Frame: 5 hours
|
The 6-minute walk test plays a key role in evaluating functional exercise capacity, assessing prognosis and evaluating response to treatment across a wide range of respiratory diseases
|
5 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Rongchang Chen, MD, Guangzhou Institute of Respiratory Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2019
Primary Completion (Anticipated)
December 31, 2021
Study Completion (Anticipated)
December 31, 2021
Study Registration Dates
First Submitted
August 9, 2019
First Submitted That Met QC Criteria
August 11, 2019
First Posted (Actual)
August 13, 2019
Study Record Updates
Last Update Posted (Actual)
February 23, 2021
Last Update Submitted That Met QC Criteria
February 20, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- GIRH-201922
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Rehabilitation
-
University of LisbonCentro Hospitalar Lisboa Norte; Fundação para a Ciência e a TecnologiaCompletedPulmonary RehabilitationPortugal
-
Karen LarimerSunovianTerminatedPulmonary Rehabilitation | COPDUnited States
-
Asan Medical CenterRecruitingPulmonary Rehabilitation | Cardiac RehabilitationKorea, Republic of
-
University Hospital, ToursCompletedPulmonary Rehabilitation | Respiratory RehabilitationFrance
-
Istanbul Medipol University HospitalRecruitingExercise | Pulmonary Rehabilitation | COPDTurkey
-
Istanbul Medipol University HospitalCompletedPulmonary Rehabilitation | Exercise Capacity | Exercise TestTurkey
-
National Cheng-Kung University HospitalCompletedTelerehabilitation | Pulmonary Rehabilitation | Compliance, Patient | COPD | Cardiopulmonary Exercise TestTaiwan
-
Asan Medical CenterRecruitingPulmonary Rehabilitation | Cardiac RehabilitationKorea, Republic of
-
Istanbul Medipol University HospitalCompletedEmphysema | Bronchoscopic Lung Volume Reduction | Hospital-based Pulmonary Rehabilitation | Home-based Pulmonary RehabilitationTurkey
-
Lifesemantics Corp.Asan Medical Center; SMG-SNU Boramae Medical Center; KangWon National University...RecruitingLung Diseases | Chronic Obstructive Pulmonary Disease | Lung Cancer | Rehabilitation | Pulmonary Rehabilitation | Respiratory Rehabilitation | Mobile Application | Asthma Copd | Respiratory System Disease | Home Based RehabilitationKorea, Republic of